Review article: current antiviral therapy of chronic hepatitis B.
about
Prevention of hepatocellular carcinoma in patients with chronic hepatitis BHepatitis B and its Relationship With Oxidative StressPhenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012.Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naïve and Treated Indonesian Patients Infected with Hepatitis B VirusHepatitis B virus management to prevent reactivation after chemotherapy: a review.Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathwayA Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.Viral Load Pattern Among Hepatitis B Surface Antigen-positive Patients: Laboratory Perspective and Implications for Therapy.Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.Enhanced HBsAg synthesis correlates with increased severity of fibrosis in chronic hepatitis B patients.Then and now: the progress in hepatitis B treatment over the past 20 years.HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy.Management of rheumatic disease with comorbid HBV or HCV infection.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxisTreatment of children with chronic viral hepatitis: what is available and what is in store.A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma.Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.Use of telemedicine technologies in the management of infectious diseases: a review.Antiviral treatment for hepatitis B virus recurrence following liver transplantation.Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.Hepatitis B: Working Towards a Cure.Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.New therapies for chronic hepatitis B.Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication).CRISPR/Cas9: the Jedi against the dark empire of diseases.Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
P2860
Q27023997-7A0E428E-8D71-464A-9BE1-10F6C27FDC84Q28069754-0F534BEB-D341-42D8-A923-F28CF0DC59F2Q33597141-C8027C21-13BE-439B-AE2B-FDA5BFAE404AQ33693776-CAE10C73-F06B-4CB8-8CB0-67F92BF6F229Q34397738-8AA3ED28-891C-41C8-AB2B-FC76E45587B5Q35152367-5084F199-C6BA-4E59-836B-520B227D9D4DQ35230043-FB0FF8BC-EB68-426A-8E3F-46A27D55C94FQ36653514-8F1484FF-CCD2-4E40-B733-87552CBBDBF6Q36740003-C3D89A82-23BA-4D67-9B2B-865BDC35C0CDQ36899457-FFFF4F29-E2F0-479D-B788-BE73BEA28513Q37254885-1D1B7D75-E0B6-4022-9F47-29B46EC145E8Q37538710-8F7A9B05-2EDD-4641-9263-46DCC03C3226Q37581346-0A961A6B-3DB0-4934-A394-506E4A29A234Q37708188-76CD5711-52C0-4D41-9BA6-99E339D0BE7BQ38008173-3837BA33-9A1D-4D35-9D07-90E583BD6F43Q38058545-EF5F42BC-EFF0-4AF1-A909-C1B54D9BD713Q38074646-C68307AD-F387-4284-A5C5-A4F33689F6B9Q38094015-90EDF9B6-A7D0-417F-B625-556E0A8A447CQ38127616-4B6A8539-467F-4738-9750-EC714416B485Q38134777-8535E34D-5480-4408-A9C9-32902F7371D3Q38235053-49EA358B-8A4E-4579-93B2-60929E354651Q38291217-AF760543-4D75-44E3-8C4C-57E12FEC7575Q38446412-42153433-C51C-42B6-9EF9-3127C91DEBB7Q38539281-C1A696A6-52F6-4820-8A00-0D58EED8ECF9Q38566984-7521505B-5363-4445-9615-EAF2167F4DAEQ38665203-0984E29B-6586-44C7-9E20-DB8D6E1F42AFQ38725759-1F904E79-4285-407A-8AD6-0F760131877DQ40707320-9A58489F-3FFD-4AF0-BEBC-F0F03F92A651Q54216562-8FDE8F25-F121-4FC7-A689-2541C66F2F5AQ55263970-D3BE944A-B49E-43D0-9173-C92542A887B4Q58759982-3F010191-D27E-41F5-AA5D-013E006CFB21
P2860
Review article: current antiviral therapy of chronic hepatitis B.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review article: current antiviral therapy of chronic hepatitis B.
@en
Review article: current antiviral therapy of chronic hepatitis B.
@nl
type
label
Review article: current antiviral therapy of chronic hepatitis B.
@en
Review article: current antiviral therapy of chronic hepatitis B.
@nl
prefLabel
Review article: current antiviral therapy of chronic hepatitis B.
@en
Review article: current antiviral therapy of chronic hepatitis B.
@nl
P2860
P1476
Review article: current antiviral therapy of chronic hepatitis B.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04869.X
P407
P577
2011-10-07T00:00:00Z